5'-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 3, 2011-01 ,pp. : 206-216

Bentham Science Publishers

Access to resources Recommend Favorite

Differential involvement of 3′, 5′-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal

By Almela Pilar   Cerezo Manuela   González-Cuello A.   Milanés M.   Laorden M.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 4, 2007-01 ,pp. : 293-303

Springer Publishing Company

Access to resources Recommend Favorite

The effect of verbascoside on cyclic 3',5'-adenosine monophosphate levels in isolated rat heart

By Pennacchio M.   Alexander E.   Syah Y.M.   Ghisalberti E.L.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 169-171

Elsevier

Access to resources Recommend Favorite

Evidence suggesting that the angiotensin II-sensitive intracellular Ca 2+ pool is reloaded from the external space in adrenal glomerulosa cells - Effects of potassium, adrenocorticotropin hormone, 5-hydroxytryptamine, adenosine 3',5'-cyclic monophosphate and angiotensin II and III

By Foster R.H.   Rojas A.M.  

General Pharmacology, Vol. 32, Iss. 2, 1999-02 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells

By Kenis G.   Steinbusch H.   De Baets M.   Maes M.  

European Neuropsychopharmacology, Vol. 13, Iss. 1, 2003-01 ,pp. : 53-56

Elsevier

Access to resources Recommend Favorite